← Back to patent-cliff list
SNP-ACTH (1-39) Gel
Tier C — Watch / tradeSNP-ACTH (1-39) Gel
Cerium Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：膜性肾小球肾炎
Regional status
US
Phase III
2023-03-13
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SNP-ACTH (1-39) Gel?
Approved indications include: 膜性肾小球肾炎.
When does the SNP-ACTH (1-39) Gel patent expire?
No public expiry year is available for SNP-ACTH (1-39) Gel yet; this page updates once verified.
How do I get a quote for SNP-ACTH (1-39) Gel intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03